Antihypertensive agents, insulin sensitivity, and new-onset diabetes (Q36839921)

16 August 2017

1 reference

title

Antihypertensive agents, insulin sensitivity, and new-onset diabetes (English)

1 reference

16 August 2017

Pantelis A Sarafidis

1

1 reference

PubMed ID

17547836

16 August 2017

Samy I McFarlane

series ordinal

2

1 reference

PubMed ID

17547836

16 August 2017

George L Bakris

series ordinal

3

1 reference

16 August 2017

1 June 2007

1 reference

16 August 2017

Current diabetes report

1 reference

16 August 2017

7

1 reference

16 August 2017

3

1 reference

16 August 2017

191-199

1 reference

https://scigraph.springernature.com/pub.10.1007/s11892-007-0031-5

16 August 2017

0 references

cites work

Effects of low dose versus conventional dose thiazide diuretic on insulin action in essential hypertension

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-007-0031-5

Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11892-007-0031-5

A double blind comparison of the effects of amlodipine and enalapril on insulin sensitivity in hypertensive patients

21 January 2018

1 reference

12 December 2020

Moxonidine improves insulin sensitivity in insulin-resistant hypertensives

1 reference

12 December 2020

Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension

1 reference

12 December 2020

Insulin resistance and cardiovascular disease

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

New treatment strategies for patients with hypertension and insulin resistance

1 reference

12 December 2020

Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group

1 reference

12 December 2020

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

12 December 2020

Molecular activation of PPARgamma by angiotensin II type 1-receptor antagonists

1 reference

12 December 2020

The effects of thiazolidinediones on blood pressure levels - a systematic review

1 reference

12 December 2020

Sensitivity to insulin during treatment with atenolol and metoprolol: a randomised, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients

1 reference

12 December 2020

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

12 December 2020

Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome

1 reference

12 December 2020

Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial

1 reference

12 December 2020

Captopril enhances insulin responsiveness of forearm muscle tissue in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes

1 reference

12 December 2020

Gender disparity in outcomes of care and management for diabetes and the metabolic syndrome

1 reference

12 December 2020

A comparison of the effects of low- and conventional-dose thiazide diuretic on insulin action in hypertensive patients with NIDDM.

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension

1 reference

12 December 2020

Effect of ramipril on the incidence of diabetes

1 reference

12 December 2020

Influence of nebivolol and enalapril on metabolic parameters and arterial stiffness in hypertensive type 2 diabetic patients

1 reference

12 December 2020

Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial.

1 reference

12 December 2020

Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril.

1 reference

12 December 2020

Association between serum lipids, glucose tolerance, and insulin sensitivity during 12 months of celiprolol treatment.

1 reference

12 December 2020

The metabolic syndrome: a glance at its history

1 reference

12 December 2020

Adverse prognostic significance of new diabetes in treated hypertensive subjects

1 reference

12 December 2020

Hemodynamic and biochemical changes after chronic administration of cilazapril to hypertensive patients.

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial

1 reference

12 December 2020

Improvement of insulin sensitivity by a long-acting nifedipine preparation (nifedipine-CR) in patients with essential hypertension

1 reference

12 December 2020

Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study.

1 reference

12 December 2020

Metabolic outcome during 1 year in newly detected hypertensives: results of the Antihypertensive Treatment and Lipid Profile in a North of Sweden Efficacy Evaluation (ALPINE study).

1 reference

12 December 2020

Effects of valsartan compared to amlodipine on preventing type 2 diabetes in high-risk hypertensive patients: the VALUE trial.

1 reference

12 December 2020

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

1 reference

12 December 2020

A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.

1 reference

12 December 2020

Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome

1 reference

12 December 2020

Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000.

1 reference

12 December 2020

A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension

1 reference

12 December 2020

Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study

1 reference

12 December 2020

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

12 December 2020

Treatment with a beta-blocker with beta 2-agonism improves glucose and lipid metabolism in essential hypertension

1 reference

12 December 2020

Metabolic effects of anti-hypertensive treatment with nifedipine or furosemide: a double-blind, cross-over study.

1 reference

12 December 2020

Comparative effects of candesartan and hydrochlorothiazide on blood pressure, insulin sensitivity, and sympathetic drive in obese hypertensive individuals: results of the CROSS study

1 reference

12 December 2020

Antihypertensive therapy and the risk of new-onset diabetes

1 reference

12 December 2020

The importance of blood pressure control in the patient with diabetes

1 reference

12 December 2020

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT).

1 reference

12 December 2020

Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity

1 reference

12 December 2020

Effects of nebivolol and atenolol on insulin sensitivity and haemodynamics in hypertensive patients

1 reference

12 December 2020

Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effect of chronic ACE inhibition on glucose tolerance and insulin sensitivity in hypertensive type 2 diabetic patients

1 reference

12 December 2020

Effect of Antihypertensive Drugs on Insulin, Glucose, and Lipid Metabolism

1 reference

12 December 2020

Metabolic effects of hydrochlorothiazide and enalapril during treatment of the hypertensive diabetic patient. Enalapril for hypertensive diabetics.

1 reference

12 December 2020

Metabolic effects of diltiazem and atenolol: results from a randomized, double-blind study with parallel groups.

1 reference

12 December 2020

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study

1 reference

12 December 2020

Antihypertensive medications and the risk of incident type 2 diabetes

1 reference

12 December 2020

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (A

1 reference

12 December 2020

Metabolic effects of pindolol and propranolol in a double-blind cross-over study in hypertensive patients

1 reference

12 December 2020

Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans

1 reference

12 December 2020

Actions of peroxisome proliferator-activated receptors-gamma agonists explaining a possible blood pressure-lowering effect

1 reference

12 December 2020

Antihypertensive therapy and incidence of type 2 diabetes: a systematic review

1 reference

12 December 2020

Metabolic effects of isradipine as monotherapy or in combination with pindolol during long-term antihypertensive treatment

1 reference

12 December 2020

Do the metabolic effects of beta blockers make them leading or supporting antihypertensive agents in the treatment of hypertension?

1 reference

12 December 2020

Normalization of insulin resistance in non-obese essential hypertension by cilazapril treatment

1 reference

12 December 2020

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study

1 reference

12 December 2020

Metabolic effects of doxazosin and enalapril in hypertriglyceridemic, hypertensive men. Relationship to changes in skeletal muscle blood flow.

1 reference

12 December 2020

Comparison of effects of captopril used either alone or in combination with a thiazide diuretic on insulin action in hypertensive Type 2 diabetic patients: a double-blind crossover study.

1 reference

12 December 2020

Efficacy and tolerability of rilmenidine compared with isradipine in hypertensive patients with features of metabolic syndrome

1 reference

12 December 2020

Metabolic effects of beta-blockers: importance of dissociating newer from conventional agents

1 reference

12 December 2020

10.1007/S11892-007-0031-5

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17547836